Specialty Oncology
-
Featured
Biomarkers of T Cell Exhaustion in Checkpoint Inhibitor Therapy
Could altering the balance between two CD8+ T cell states enhance immunotherapies? Research from the Massachusetts General Hospital Cancer Center seeks to find the answer.
-
Mass General Offers Novel, Kidney-saving Urothelial Cancer Treatment
Mitomycin chemoablation with a mitomycin gel, a novel treatment offered in the Department of Urology at Massachusetts General Hospital, can avoid the need for surgical removal of the kidney and ureter in patients with upper tract urothelial cancer.
-
Machine Learning Algorithm Leverages Use of EHRs for Lung Cancer Research
Using electronic health records, a machine learning algorithm and natural language processing, researchers at Massachusetts General Hospital assembled a large cohort that to study lung cancer progression and developed an electronic tool capable of predicting survival in non–small cell lung cancer.
-
Improving Surgical Outcomes for Patients with Colorectal Cancer
Rocco Ricciardi, MD, MPH, is chief of Colon and Rectal Surgery at Massachusetts General Hospital. In this video, he explores ways in which his research is improving surgical outcomes for patients with colorectal cancer.
-
Older Age Alone Should Not Rule Out Intensive Treatment of Aggressive Non-Hodgkin's Lymphoma
Massachusetts General Hospital researchers demonstrated that intensive therapy for aggressive non-Hodgkin's lymphoma has survival benefits across all age brackets of older adults, and they identified factors associated with greater risk of toxicities and unplanned hospitalization.
-
Advancing Trimodality Therapy for Bladder Cancer
Researchers explore long-term outcomes and options for bladder cancer recurrence after combination treatment using transurethral resection and chemoradiation.
Mass General Cancer Center Contributors
-
Andrew T. Chan, MD, MPH
Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
Research from the Clinical and Translational Epidemiology Unit: The Gut Microbiome
-
David M. Langenau, PhD
Associate Professor of Pathology, Harvard Medical School, Associate Chair for Research, Department of Pathology, Massachusetts General Hospital
-
J. Keith Joung, MD, PhD
Professor of Pathology, Harvard Medical School, Center for Cancer Research, Desmond and Ann Heathwood MGH Research Scholar
Recent Article
CRISPR Base Editors Can Induce Wide-Ranging Off-Target Edits in RNA
-
Joseph H. Schwab, MD
Chief, Orthopaedic Spine Surgery, Director, Spine Oncology & Co-Director, Stephen L. Harris Chordoma Center, Associate Professor of Orthopaedic Surgery, Harvard Medical School
Recent Article
Nutritional, Physiological Factors Affect Wound Infection After Surgery for Lower-Extremity Soft Tissue Sarcoma
-
Keith T. Flaherty, MD
Director of Clinical Research, Mass General Cancer Center, Professor of Medicine, Harvard Medical School
Recent Article
Medical Grand Rounds: Advancing New Therapies for COVID-19: Antiviral, Immunomodulation and Beyond
-
Marcela G. del Carmen, MD
Chief Medical Officer, Massachusetts General Physicians Organization and Massachusetts General Hospital, Gynecologic Oncologist, Department of Obstetrics and Gynecology, Clinician, Center for Gynecologic Oncology, Mass General Cancer Center
Recent Article
U.S. COVID-19 Test Results Strongly Correlate with Race/Ethnicity, Income
-
Marcela V. Maus, MD, PhD
Director, Cellular Immunotherapy Program, Mass General Cancer Center, Assistant Professor of Medicine, Harvard Medical School
Recent Article
CAR T-cell Therapy Feasible for Active Secondary CNS Lymphoma -
Nir Hacohen, PhD
Director, MGH Center for Cancer Immunology
Center for Cancer Research , Professor of Medicine, Harvard Medical School, Senior Member, Broad InstituteRecent Article
Mass General Researchers Find Link Between Protein Signature and Severe Health Decline in COVID-19 Patients
-
Raul Mostoslavsky, MD, PhD
Laurel Schwartz Professor of Medicine in the Field of Oncology, Mass General Cancer Center, Center for Cancer Research
Recent Article
Inactivating Mutation in the Histone Deacetylase SIRT6 Discovered to Be a Cause of Fetal Demise
-
William T. Curry, MD
Co-Director, Mass General Neuroscience , Director of Neurosurgical Oncology
Recent Article
Immunotherapies to Treat Glioblastoma
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
